nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—P2RX4—nerve—acquired immunodeficiency syndrome	0.0319	0.057	CbGeAlD
Suramin—SIRT1—nerve—acquired immunodeficiency syndrome	0.0279	0.0499	CbGeAlD
Suramin—SIRT1—endothelium—acquired immunodeficiency syndrome	0.0238	0.0425	CbGeAlD
Suramin—P2RY2—blood—acquired immunodeficiency syndrome	0.0151	0.027	CbGeAlD
Suramin—PLA2G2A—blood plasma—acquired immunodeficiency syndrome	0.0148	0.0264	CbGeAlD
Suramin—P2RY2—lung—acquired immunodeficiency syndrome	0.0133	0.0237	CbGeAlD
Suramin—F2—endothelium—acquired immunodeficiency syndrome	0.0126	0.0225	CbGeAlD
Suramin—F2—blood plasma—acquired immunodeficiency syndrome	0.0112	0.02	CbGeAlD
Suramin—PLA2G4A—blood plasma—acquired immunodeficiency syndrome	0.0103	0.0184	CbGeAlD
Suramin—ARSA—skin of body—acquired immunodeficiency syndrome	0.01	0.0179	CbGeAlD
Suramin—SIRT5—blood—acquired immunodeficiency syndrome	0.00934	0.0167	CbGeAlD
Suramin—P2RX4—blood—acquired immunodeficiency syndrome	0.00883	0.0158	CbGeAlD
Suramin—SIRT5—vagina—acquired immunodeficiency syndrome	0.00866	0.0155	CbGeAlD
Suramin—P2RX4—bone marrow—acquired immunodeficiency syndrome	0.00855	0.0153	CbGeAlD
Suramin—P2RX4—spinal cord—acquired immunodeficiency syndrome	0.00851	0.0152	CbGeAlD
Suramin—SIRT1—lymphoid tissue—acquired immunodeficiency syndrome	0.00823	0.0147	CbGeAlD
Suramin—SIRT5—lung—acquired immunodeficiency syndrome	0.00819	0.0146	CbGeAlD
Suramin—P2RX4—vagina—acquired immunodeficiency syndrome	0.00819	0.0146	CbGeAlD
Suramin—SIRT1—digestive system—acquired immunodeficiency syndrome	0.00813	0.0145	CbGeAlD
Suramin—ARSA—lymphoid tissue—acquired immunodeficiency syndrome	0.00813	0.0145	CbGeAlD
Suramin—ARSA—digestive system—acquired immunodeficiency syndrome	0.00803	0.0143	CbGeAlD
Suramin—P2RX4—lung—acquired immunodeficiency syndrome	0.00774	0.0138	CbGeAlD
Suramin—SIRT1—blood—acquired immunodeficiency syndrome	0.00774	0.0138	CbGeAlD
Suramin—ARSA—blood—acquired immunodeficiency syndrome	0.00765	0.0137	CbGeAlD
Suramin—SIRT5—nervous system—acquired immunodeficiency syndrome	0.00758	0.0136	CbGeAlD
Suramin—SIRT1—bone marrow—acquired immunodeficiency syndrome	0.00749	0.0134	CbGeAlD
Suramin—SIRT1—spinal cord—acquired immunodeficiency syndrome	0.00746	0.0133	CbGeAlD
Suramin—ARSA—spinal cord—acquired immunodeficiency syndrome	0.00737	0.0132	CbGeAlD
Suramin—SIRT5—central nervous system—acquired immunodeficiency syndrome	0.0073	0.0131	CbGeAlD
Suramin—SIRT1—vagina—acquired immunodeficiency syndrome	0.00718	0.0128	CbGeAlD
Suramin—P2RX4—nervous system—acquired immunodeficiency syndrome	0.00717	0.0128	CbGeAlD
Suramin—RYR1—blood—acquired immunodeficiency syndrome	0.00715	0.0128	CbGeAlD
Suramin—ARSA—vagina—acquired immunodeficiency syndrome	0.00709	0.0127	CbGeAlD
Suramin—P2RX4—central nervous system—acquired immunodeficiency syndrome	0.00691	0.0123	CbGeAlD
Suramin—SIRT1—lung—acquired immunodeficiency syndrome	0.00679	0.0121	CbGeAlD
Suramin—ARSA—lung—acquired immunodeficiency syndrome	0.0067	0.012	CbGeAlD
Suramin—RYR1—vagina—acquired immunodeficiency syndrome	0.00663	0.0118	CbGeAlD
Suramin—SIRT1—nervous system—acquired immunodeficiency syndrome	0.00628	0.0112	CbGeAlD
Suramin—ARSA—nervous system—acquired immunodeficiency syndrome	0.00621	0.0111	CbGeAlD
Suramin—SIRT1—central nervous system—acquired immunodeficiency syndrome	0.00605	0.0108	CbGeAlD
Suramin—ARSA—central nervous system—acquired immunodeficiency syndrome	0.00598	0.0107	CbGeAlD
Suramin—RYR1—nervous system—acquired immunodeficiency syndrome	0.00581	0.0104	CbGeAlD
Suramin—SIRT5—brain—acquired immunodeficiency syndrome	0.0058	0.0104	CbGeAlD
Suramin—PLA2G2A—lymphoid tissue—acquired immunodeficiency syndrome	0.00576	0.0103	CbGeAlD
Suramin—PLA2G2A—digestive system—acquired immunodeficiency syndrome	0.00569	0.0102	CbGeAlD
Suramin—SIRT5—lymph node—acquired immunodeficiency syndrome	0.0056	0.01	CbGeAlD
Suramin—RYR1—central nervous system—acquired immunodeficiency syndrome	0.00559	0.00999	CbGeAlD
Suramin—P2RX4—brain—acquired immunodeficiency syndrome	0.00548	0.0098	CbGeAlD
Suramin—PLA2G2A—blood—acquired immunodeficiency syndrome	0.00542	0.00969	CbGeAlD
Suramin—P2RX4—lymph node—acquired immunodeficiency syndrome	0.0053	0.00947	CbGeAlD
Suramin—SIRT1—brain—acquired immunodeficiency syndrome	0.0048	0.00859	CbGeAlD
Suramin—PLA2G2A—lung—acquired immunodeficiency syndrome	0.00475	0.00849	CbGeAlD
Suramin—ARSA—brain—acquired immunodeficiency syndrome	0.00474	0.00848	CbGeAlD
Suramin—SIRT1—lymph node—acquired immunodeficiency syndrome	0.00464	0.0083	CbGeAlD
Suramin—ARSA—lymph node—acquired immunodeficiency syndrome	0.00458	0.00819	CbGeAlD
Suramin—RYR1—brain—acquired immunodeficiency syndrome	0.00444	0.00793	CbGeAlD
Suramin—PLA2G2A—nervous system—acquired immunodeficiency syndrome	0.0044	0.00786	CbGeAlD
Suramin—F2—lymphoid tissue—acquired immunodeficiency syndrome	0.00435	0.00777	CbGeAlD
Suramin—F2—digestive system—acquired immunodeficiency syndrome	0.0043	0.00768	CbGeAlD
Suramin—PLA2G2A—central nervous system—acquired immunodeficiency syndrome	0.00424	0.00757	CbGeAlD
Suramin—F2—blood—acquired immunodeficiency syndrome	0.00409	0.00731	CbGeAlD
Suramin—F2—bone marrow—acquired immunodeficiency syndrome	0.00396	0.00708	CbGeAlD
Suramin—F2—spinal cord—acquired immunodeficiency syndrome	0.00394	0.00705	CbGeAlD
Suramin—PLA2G4A—blood—acquired immunodeficiency syndrome	0.00377	0.00674	CbGeAlD
Suramin—P2RY2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.0037	0.00839	CbGpPWpGaD
Suramin—PLA2G4A—bone marrow—acquired immunodeficiency syndrome	0.00365	0.00652	CbGeAlD
Suramin—PLA2G4A—spinal cord—acquired immunodeficiency syndrome	0.00363	0.00649	CbGeAlD
Suramin—F2—lung—acquired immunodeficiency syndrome	0.00359	0.00641	CbGeAlD
Suramin—FSHR—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00357	0.0081	CbGpPWpGaD
Suramin—PLA2G4A—vagina—acquired immunodeficiency syndrome	0.00349	0.00624	CbGeAlD
Suramin—F2—Syndecan-4-mediated signaling events—CCL5—acquired immunodeficiency syndrome	0.00344	0.0078	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.00341	0.00775	CbGpPWpGaD
Suramin—PLA2G2A—brain—acquired immunodeficiency syndrome	0.00336	0.00601	CbGeAlD
Suramin—P2RY2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00334	0.00759	CbGpPWpGaD
Suramin—F2—nervous system—acquired immunodeficiency syndrome	0.00332	0.00594	CbGeAlD
Suramin—PLA2G4A—lung—acquired immunodeficiency syndrome	0.0033	0.0059	CbGeAlD
Suramin—PLA2G2A—Spinal Cord Injury—CCR2—acquired immunodeficiency syndrome	0.00328	0.00745	CbGpPWpGaD
Suramin—PLA2G2A—lymph node—acquired immunodeficiency syndrome	0.00325	0.00581	CbGeAlD
Suramin—ARSA—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.00324	0.00735	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00323	0.00733	CbGpPWpGaD
Suramin—F2—central nervous system—acquired immunodeficiency syndrome	0.0032	0.00572	CbGeAlD
Suramin—P2RY2—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00316	0.00718	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00313	0.00711	CbGpPWpGaD
Suramin—PLA2G4A—nervous system—acquired immunodeficiency syndrome	0.00306	0.00547	CbGeAlD
Suramin—FSHR—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00306	0.00694	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00302	0.00686	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.003	0.00681	CbGpPWpGaD
Suramin—P2RY2—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00298	0.00675	CbGpPWpGaD
Suramin—PLA2G4A—central nervous system—acquired immunodeficiency syndrome	0.00295	0.00526	CbGeAlD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.0029	0.00657	CbGpPWpGaD
Suramin—FSHR—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00287	0.00652	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00271	0.00616	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00262	0.00594	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00255	0.00579	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00255	0.00579	CbGpPWpGaD
Suramin—F2—brain—acquired immunodeficiency syndrome	0.00254	0.00454	CbGeAlD
Suramin—F2—IL1 and megakaryotyces in obesity—IFNG—acquired immunodeficiency syndrome	0.00253	0.00575	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00246	0.00559	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00246	0.00559	CbGpPWpGaD
Suramin—F2—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	0.00237	0.00537	CbGpPWpGaD
Suramin—PLA2G4A—brain—acquired immunodeficiency syndrome	0.00234	0.00418	CbGeAlD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00229	0.0052	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00228	0.00518	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	0.00227	0.00516	CbGpPWpGaD
Suramin—PLA2G4A—lymph node—acquired immunodeficiency syndrome	0.00226	0.00404	CbGeAlD
Suramin—FSHR—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.0022	0.00501	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—ACTG1—acquired immunodeficiency syndrome	0.00218	0.00494	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.00209	0.00474	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.00207	0.00469	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00206	0.00469	CbGpPWpGaD
Suramin—P2RY2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00204	0.00463	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00199	0.00453	CbGpPWpGaD
Suramin—FSHR—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00197	0.00447	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00194	0.00441	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00194	0.00441	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00194	0.0044	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.0019	0.00431	CbGpPWpGaD
Suramin—SIRT1—Signaling events mediated by HDAC Class I—TNF—acquired immunodeficiency syndrome	0.00188	0.00427	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00187	0.00426	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00187	0.00426	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00187	0.00425	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.00187	0.00424	CbGpPWpGaD
Suramin—F2—Folate Metabolism—IL4—acquired immunodeficiency syndrome	0.00187	0.00424	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00185	0.0042	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00183	0.00416	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00179	0.00405	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00175	0.00397	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00174	0.00396	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00171	0.00389	CbGpPWpGaD
Suramin—F2—FOXA2 and FOXA3 transcription factor networks—ALB—acquired immunodeficiency syndrome	0.00171	0.00388	CbGpPWpGaD
Suramin—ARSA—Metabolism—TAT—acquired immunodeficiency syndrome	0.0017	0.00385	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00169	0.00383	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00166	0.00376	CbGpPWpGaD
Suramin—PLA2G2A—Cardiac Hypertrophic Response—TNF—acquired immunodeficiency syndrome	0.00164	0.00372	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.00162	0.00367	CbGpPWpGaD
Suramin—F2—Vitamin B12 Metabolism—ALB—acquired immunodeficiency syndrome	0.00152	0.00345	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00148	0.00335	CbGpPWpGaD
Suramin—ARSA—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00144	0.00328	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00143	0.00324	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00139	0.00315	CbGpPWpGaD
Suramin—F2—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	0.00139	0.00315	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	0.00138	0.00312	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00133	0.00302	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—CCNT1—acquired immunodeficiency syndrome	0.00133	0.00302	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00128	0.00292	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.00128	0.0029	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00125	0.00285	CbGpPWpGaD
Suramin—F2—Folate Metabolism—ALB—acquired immunodeficiency syndrome	0.00124	0.00281	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	0.00122	0.00277	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00117	0.00266	CbGpPWpGaD
Suramin—PLA2G2A—MicroRNAs in cardiomyocyte hypertrophy—TNF—acquired immunodeficiency syndrome	0.00117	0.00265	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00117	0.00265	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.00116	0.00262	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00113	0.00257	CbGpPWpGaD
Suramin—F2—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	0.00113	0.00256	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00113	0.00256	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00112	0.00254	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00112	0.00254	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.0011	0.00249	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.0011	0.00249	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—TAT—acquired immunodeficiency syndrome	0.00109	0.00248	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.00109	0.00247	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.00109	0.00247	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00108	0.00246	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00108	0.00246	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00106	0.00241	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00106	0.00241	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00106	0.00241	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00106	0.0024	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00102	0.00232	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00101	0.0023	CbGpPWpGaD
Suramin—F2—Folate Metabolism—IL2—acquired immunodeficiency syndrome	0.001	0.00227	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000996	0.00226	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000996	0.00226	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000983	0.00223	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.000982	0.00223	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000978	0.00222	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000962	0.00218	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000962	0.00218	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000955	0.00217	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00093	0.00211	CbGpPWpGaD
Suramin—RYR1—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	0.00092	0.00209	CbGpPWpGaD
Suramin—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—acquired immunodeficiency syndrome	0.000911	0.00207	CbGpPWpGaD
Suramin—F2—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	0.000897	0.00204	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.000896	0.00203	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000894	0.00203	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	0.00089	0.00202	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000857	0.00194	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	0.000843	0.00191	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000835	0.00189	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000826	0.00188	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000822	0.00187	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000818	0.00186	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000806	0.00183	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000801	0.00182	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000794	0.0018	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000775	0.00176	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000758	0.00172	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000752	0.00171	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000746	0.00169	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000744	0.00169	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000732	0.00166	CbGpPWpGaD
Suramin—F2—Folate Metabolism—TNF—acquired immunodeficiency syndrome	0.00073	0.00166	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000728	0.00165	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000728	0.00165	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000726	0.00165	CbGpPWpGaD
Suramin—F2—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	0.000724	0.00164	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	0.000721	0.00164	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000721	0.00164	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	0.000718	0.00163	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000692	0.00157	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000683	0.00155	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000668	0.00152	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000664	0.00151	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	0.00066	0.0015	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000659	0.0015	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000653	0.00148	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000652	0.00148	CbGpPWpGaD
Suramin—RYR1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000648	0.00147	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000626	0.00142	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000604	0.00137	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00059	0.00134	CbGpPWpGaD
Suramin—F2—Folate Metabolism—IL6—acquired immunodeficiency syndrome	0.000589	0.00134	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000588	0.00134	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000588	0.00134	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.00058	0.00132	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000568	0.00129	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000568	0.00129	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000555	0.00126	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000555	0.00126	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000554	0.00126	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000542	0.00123	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000528	0.0012	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—IL6—acquired immunodeficiency syndrome	0.000525	0.00119	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—TAT—acquired immunodeficiency syndrome	0.000515	0.00117	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000499	0.00113	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000496	0.00113	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00049	0.00111	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000483	0.0011	CbGpPWpGaD
Suramin—F2—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.000475	0.00108	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	0.00047	0.00107	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.000468	0.00106	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000448	0.00102	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000448	0.00102	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000441	0.001	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000438	0.000994	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.000434	0.000986	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000434	0.000986	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000432	0.000982	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	0.00043	0.000976	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000428	0.000972	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000426	0.000967	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000422	0.000958	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.00042	0.000952	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000403	0.000916	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000394	0.000896	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.00039	0.000884	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.000381	0.000865	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000381	0.000865	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00038	0.000863	CbGpPWpGaD
Suramin—F2—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000372	0.000844	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.000349	0.000791	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.00034	0.000772	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000335	0.00076	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000333	0.000757	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00032	0.000727	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00032	0.000727	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000313	0.000712	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000313	0.000712	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000306	0.000695	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000303	0.000687	CbGpPWpGaD
Suramin—ARSA—Metabolism—ALB—acquired immunodeficiency syndrome	0.000296	0.000672	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000293	0.000665	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000293	0.000665	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000289	0.000657	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	0.000285	0.000648	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000285	0.000646	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000285	0.000646	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000277	0.000629	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000265	0.000601	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00026	0.000591	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00026	0.000591	CbGpPWpGaD
Suramin—F2—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000242	0.00055	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000238	0.000541	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000235	0.000533	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000233	0.000529	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000232	0.000526	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000229	0.00052	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000225	0.000511	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000224	0.000508	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000222	0.000503	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000217	0.000492	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000215	0.000488	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000213	0.000484	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000202	0.000458	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000198	0.00045	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000198	0.000449	CbGpPWpGaD
Suramin—F2—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000196	0.000446	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000195	0.000443	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000195	0.000443	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—ALB—acquired immunodeficiency syndrome	0.000191	0.000433	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000181	0.000411	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—IL2—acquired immunodeficiency syndrome	0.00018	0.000408	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000179	0.000406	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000178	0.000405	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000168	0.000382	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000168	0.000382	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000164	0.000371	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000154	0.000349	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000154	0.000349	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000137	0.000311	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000132	0.0003	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000128	0.00029	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000126	0.000286	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000124	0.000282	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000117	0.000266	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000115	0.000262	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000115	0.000262	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000113	0.000256	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000105	0.000239	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000103	0.000234	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ALB—acquired immunodeficiency syndrome	8.98e-05	0.000204	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.66e-05	0.000151	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.63e-05	0.00015	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.09e-05	0.000138	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.06e-05	0.000138	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.91e-05	8.89e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.58e-05	8.13e-05	CbGpPWpGaD
